August 31, 2012
The company consolidates product divisions and shuffles its executive leadership.
The company has received FDA clearance for the device.
Company says trial results best Medtronic’s Endeavor stent.
The company’s Costa Rica plant is under scrutiny by the FDA.
The investment is in line with China’s current focus on biotechnology.
The company is beginning the process to release the device in the United States.
Sirigen is a Nobel Prize winning polymer technology company.
Getinge hopes to bring the Therapeutic Support Systems business to its European markets.
The valve is a new version of the company’s older sterilization product.
The company hopes to establish Jarvik device’s superiority to others on the market.
Siemens will bolster its ultrasound business with the purchase.
Millennium Research Group cites market saturation for the sluggish growth prediction.
Zoll’s wearable defibrillator will now benefit from Inovise’s acoustic cardiography technology.
The graft is designed to facilitate sutureless anastomosis, among other applications.
The new hire joins Toshiba from Philips Healthcare.
GE and Orbimed join to invest in the oxygen monitoring device company.
The new two new microcoil systems are available in the United States and Europe.
Helix will acquire half of all company shares by next year.
The company will develop a biothreat detection instrument.
The agency hopes to further speed up review times with this guidance.
The results are good: The company can replicate lowered blood pressure both in office and over 24-hour monitoring.
The lancet comes in sizes for newborns and preemies.
The company promotes COO to CEO position.
CEO has experience in both medical devices and contract manufacturing.
The purchase will beef up Teleflex’s anesthesia business.
The system delivers baclofen for the treatment of spasticity.
The device is intended to treat iliac artery disease.
The acquisition prompts a revision of Masimo’s financial predictions for 2012.
The suture has been in use since 2004.
New hire brings 15 years experience in sales and marketing.
Kevin King replaces Bill Willis on the board.
The SFDA announced the new procedure on June 18.
The device is a new addition to the SuperCross product line.
The system is designed to help physicians monitor oxygen levels more quickly.
Studies show elevated exposure could have emasculating effects on male patients.
Semprus BioSciences division gains EU clearance for catheter technology.
The company’s Mexico facility has been awarded an ISO 13485 certification.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.